NCT02406521
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
NCT02406521
NCT00960999
NCT02700659
NCT04295174
NCT01775930
NCT02014636
NCT01347333
NCT03663985
NCT01697800
NCT02060370